1. Home
  2. BDSX vs KOSS Comparison

BDSX vs KOSS Comparison

Compare BDSX & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • KOSS
  • Stock Information
  • Founded
  • BDSX 2005
  • KOSS 1953
  • Country
  • BDSX United States
  • KOSS United States
  • Employees
  • BDSX N/A
  • KOSS N/A
  • Industry
  • BDSX Precision Instruments
  • KOSS Consumer Electronics/Appliances
  • Sector
  • BDSX Health Care
  • KOSS Consumer Staples
  • Exchange
  • BDSX Nasdaq
  • KOSS Nasdaq
  • Market Cap
  • BDSX 53.0M
  • KOSS 49.1M
  • IPO Year
  • BDSX 2020
  • KOSS N/A
  • Fundamental
  • Price
  • BDSX $6.57
  • KOSS $5.05
  • Analyst Decision
  • BDSX Strong Buy
  • KOSS
  • Analyst Count
  • BDSX 5
  • KOSS 0
  • Target Price
  • BDSX $32.50
  • KOSS N/A
  • AVG Volume (30 Days)
  • BDSX 276.0K
  • KOSS 58.4K
  • Earning Date
  • BDSX 11-03-2025
  • KOSS 10-28-2025
  • Dividend Yield
  • BDSX N/A
  • KOSS N/A
  • EPS Growth
  • BDSX N/A
  • KOSS N/A
  • EPS
  • BDSX N/A
  • KOSS N/A
  • Revenue
  • BDSX $76,556,000.00
  • KOSS $12,624,170.00
  • Revenue This Year
  • BDSX $18.78
  • KOSS N/A
  • Revenue Next Year
  • BDSX $26.42
  • KOSS N/A
  • P/E Ratio
  • BDSX N/A
  • KOSS N/A
  • Revenue Growth
  • BDSX 25.70
  • KOSS 2.93
  • 52 Week Low
  • BDSX $3.44
  • KOSS $4.00
  • 52 Week High
  • BDSX $34.39
  • KOSS $8.59
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 52.63
  • KOSS 45.66
  • Support Level
  • BDSX $5.84
  • KOSS $5.04
  • Resistance Level
  • BDSX $6.94
  • KOSS $5.30
  • Average True Range (ATR)
  • BDSX 0.61
  • KOSS 0.30
  • MACD
  • BDSX -0.27
  • KOSS 0.03
  • Stochastic Oscillator
  • BDSX 34.52
  • KOSS 33.67

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

Share on Social Networks: